Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Dean Y Maeda"'
Autor:
Jeffrey Schlom, Claudia Palena, Kristen Fousek, Zhen Su, Duane H Hamilton, Hanne Lind, Lucas A Horn, Jeffrey Riskin, Heidi A Hempel, Kristen K McCampbell, Dean Y Maeda, John A Zebala
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Despite the success of immune checkpoint blockade therapy in the treatment of certain cancer types, only a small percentage of patients with solid malignancies achieve a durable response. Consequently, there is a need to develop novel appr
Externí odkaz:
https://doaj.org/article/13511483f12b409eb6e9c8522f26161d
Autor:
Lucas A. Horn, Hanne Lind, Kristen Fousek, Haiyan Qin, Nika Rajabian, Shantel Angstadt, Nicole Hsiao-Sanchez, Miriam M. Medina-Enriquez, Marcus D. Kelly, Clint T. Allen, Sarah M. Hammoudeh, Roberto Weigert, Dean Y. Maeda, John A. Zebala, Claudia Palena
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-22 (2024)
Abstract Background Relapsed head and neck squamous cell carcinoma (HNSCC) unrelated to HPV infection carries a poor prognosis. Novel approaches are needed to improve the clinical outcome and prolong survival in this patient population which has poor
Externí odkaz:
https://doaj.org/article/66927b8d4cfe4aeca811e4aff6bc75e1
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2020)
Tramadol is widely used globally and is the second most prescribed opioid in the United States. It treats moderate to severe pain but lethal opioid-induced respiratory depression is uncommon even in large overdose. It is unknown why tramadol spares r
Externí odkaz:
https://doaj.org/article/02111778d07a4ee8a972583f7ab1f827
Autor:
David A. Sallman, Amy E. DeZern, Arlene A. Gayle, Stuart J. Kahn, Eric Padron, Jeffrey E. Lancet, Andrew Kuykendall, Kendra Sweet, Onyee Chan, Dean Y. Maeda, Aaron D. Schuler, John A. Zebala, Rami S. Komrokji
Publikováno v:
Blood. 140:2070-2072
Figure S1-6 from Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC
Autor:
Benjamin G. Neel, Kwok-Kin Wong, Aristotelis Tsirigos, Cynthia A. Loomis, Argus Athanas, Peter Olson, James G. Christensen, Dean Y. Maeda, John A. Zebala, Carmine Fedele, Yuan Hao, Ting Chen, Kayla Guidry, Han Han, Jayu Jen, Alireza Khodadadi-Jamayran, Shuai Li, Kwan Ho Tang
Figure S1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db55b1f7b0adeca862191754700aa35
https://doi.org/10.1158/2159-8290.22540636.v1
https://doi.org/10.1158/2159-8290.22540636.v1
Autor:
Benjamin G. Neel, Kwok-Kin Wong, Aristotelis Tsirigos, Cynthia A. Loomis, Argus Athanas, Peter Olson, James G. Christensen, Dean Y. Maeda, John A. Zebala, Carmine Fedele, Yuan Hao, Ting Chen, Kayla Guidry, Han Han, Jayu Jen, Alireza Khodadadi-Jamayran, Shuai Li, Kwan Ho Tang
SHP2 inhibitors (SHP2i) alone and in various combinations are being tested in multiple tumors with overactivation of the RAS/ERK pathway. SHP2 plays critical roles in normal cell signaling; hence, SHP2is could influence the tumor microenvironment. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac5bb67a60ff5aa42b51919267a87ea
https://doi.org/10.1158/2159-8290.c.6549436.v1
https://doi.org/10.1158/2159-8290.c.6549436.v1
Autor:
Benjamin G. Neel, Kwok-Kin Wong, Aristotelis Tsirigos, Cynthia A. Loomis, Argus Athanas, Peter Olson, James G. Christensen, Dean Y. Maeda, John A. Zebala, Carmine Fedele, Yuan Hao, Ting Chen, Kayla Guidry, Han Han, Jayu Jen, Alireza Khodadadi-Jamayran, Shuai Li, Kwan Ho Tang
Table S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07fbd70898706deb6c68333d4b97a8f4
https://doi.org/10.1158/2159-8290.22540627
https://doi.org/10.1158/2159-8290.22540627
Autor:
Clint Allen, Paul E. Clavijo, John A. Zebala, Dean Y. Maeda, Jeffrey Schlom, Claudia Palena, Lucas A. Horn, Jay Friedman, Nicole C. Schmitt, Angel P. Huynh, Wojciech K. Mydlarz, Yvette Robbins, Sarah Greene
Supplemental Figure S7. SX-682 treatment does not alter PMN-MDSC suppressive capacity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d32e1729179b2c8191a3483bb36eac6
https://doi.org/10.1158/1078-0432.22478684
https://doi.org/10.1158/1078-0432.22478684
Autor:
Clint Allen, Paul E. Clavijo, John A. Zebala, Dean Y. Maeda, Jeffrey Schlom, Claudia Palena, Lucas A. Horn, Jay Friedman, Nicole C. Schmitt, Angel P. Huynh, Wojciech K. Mydlarz, Yvette Robbins, Sarah Greene
Purpose:Natural killer (NK)-cell–based immunotherapy may overcome obstacles to effective T-cell–based immunotherapy such as the presence of genomic alterations in IFN response genes and antigen presentation machinery. All immunotherapy approaches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c83b154859a3605e7859ad97fb58723
https://doi.org/10.1158/1078-0432.c.6530021.v1
https://doi.org/10.1158/1078-0432.c.6530021.v1
Autor:
Clint Allen, Paul E. Clavijo, John A. Zebala, Dean Y. Maeda, Jeffrey Schlom, Claudia Palena, Lucas A. Horn, Jay Friedman, Nicole C. Schmitt, Angel P. Huynh, Wojciech K. Mydlarz, Yvette Robbins, Sarah Greene
Methods not essential to the main conclusions but important for critical review of methods used for this work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee5ecc3ab0347cbce114b16bbcc7a4de
https://doi.org/10.1158/1078-0432.22478678.v1
https://doi.org/10.1158/1078-0432.22478678.v1